Implementation of a "DIVA" concept with specific elisa kits; when subunit H5 avian influenza vaccine is used

World Academy of Science, Engineering and Technology

Volumn 65, Issue , 2010, Pages 358-361

  Robles, F ^a   Uribe, A ^a   Guadarrama, A ^a   Castellanos, L ^a   Gonzalez C ^a  

^a Boehringer Ingelheim Vetmedica SA de CV Research and Development Department   (Mexico)

Author keywords

Avian Influenza Virus; DIVA concept; ELISA assay; Subunit H5 vaccine

Indexed keywords

AVIAN INFLUENZA; DIVA CONCEPT; ELISA ASSAY; ELISA TEST; EXPERIMENTAL GROUPS; NEURAMINIDASE; NUCLEOCAPSIDS; SUBUNIT H5 VACCINE; SUBUNIT VACCINE;

ANIMALS; ANTIBODIES; ASSAYS; CHEMICAL DETECTION; GENE TRANSFER; NUCLEIC ACIDS; VIRUSES; DISEASE CONTROL;

VACCINES;

EID: 78751632688     PISSN: 2010376X     EISSN: 20103778     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. I. Capua, C. Terregino, G. Cattoli, F. Mistinelli and J. Rodríguez."Development of a DIVA (Differentiating infected from vacinatedanimals) strategy using a vaccine containing a heterolologousneuroaminadase to control of avian influenza". Avian Patho. 32, pp. 47-55. 2002.
2. T. Ellis, L. Sims, H. Wong, C. Wong, K. Dyrting, K. Chow, C. Leungand J. Peiris. "Use of Avian Influenza Vaccination in Hong Kong". DevBiol, 124, pp. 133-143. 2006.
3. C. Lee and D. Suarez. "Avian influenza virus: prospects for preventionand control by vaccination". Animal Health Research Review. 6, pp. 1-15. 2005.
4. "Vaccination: a tool for the control of avian influenza" in OIE/FAO/IZSVe Scientific Conference, co-organised and supported by European Union, Verona (Italy), 20-22 March 2007.